Article

Depressive symptoms and survival of patients with coronary artery disease

Behavioral Medicine Research Center, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA.
Psychosomatic Medicine (Impact Factor: 4.09). 01/2000; 62(6):790-5. DOI: 10.1097/00006842-200011000-00008
Source: PubMed

ABSTRACT Multiple studies have shown that high levels of depressive symptoms increase the mortality risk of patients with established coronary disease. This investigation divided depressive symptoms into groups to assess their relative effectiveness in predicting survival.
Questionnaires about the presence of depressive symptoms were administered to 1250 patients with significant coronary disease while they were hospitalized for diagnostic coronary angiography. Follow-up for mortality due to cardiac disease was conducted annually for up to 19.4 years. Factor analysis was used to divide items on the Zung Self-Rating Depression Scale into four groups: Well-Being, Negative Affect, Somatic, and Appetite. In addition, responses to a single item regarding feelings of hopelessness were available for 920 patients.
Well-Being and Somatic symptoms significantly predicted survival (p < or = .01). Negative Affect items were also related to survival (p = .0001) and interacted with age. A 2-SD difference in the Negative Affect term was associated with a relative risk of 1.29 for patients >50 years old and 1.70 for younger ones. Only Negative Affect remained significant in a model with the other symptom groups. Hopelessness also predicted survival with a relative risk of 1.5. Both the Hopelessness and Negative Affect items remained as independent predictors in the same model. All models controlled for severity of disease and treatment. With one exception (income and Hopelessness), results were essentially unchanged by additional controls for age, gender, and income.
Depressive symptoms differentially predicted survival, with depressive affect and hopelessness being particularly important. These effects were independent of disease severity and somatic symptoms and may be especially important in younger patients.

Download full-text

Full-text

Available from: Michael J Helms, Aug 15, 2015
0 Followers
 · 
84 Views
  • Source
    • "A total of 14 studies met our inclusion criteria. However, as the authors of one study could not provide the confidence intervals (CIs) of the effect estimate, this study could not be included in the analyses (Barefoot et al. 2000). Hence a total of 13 studies were included in the meta-analysis, providing data on 11 128 patients. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several prospective longitudinal studies have suggested that somatic/affective depressive symptoms, but not cognitive/affective depressive symptoms, are related to prognosis in patients with heart disease, but findings have been inconsistent. The aim of this study was to investigate the association of cognitive/affective and somatic/affective symptoms of depression with cardiovascular prognosis in patients with heart disease using a meta-analytic perspective. A systematic search was performed in PubMed, EMBASE and PsycInfo. Thirteen prospective studies on symptom dimensions of depression and cardiovascular prognosis fulfilled the inclusion criteria, providing data on a total of 11 128 subjects. The risk estimates for each dimension of depressive symptoms, demographic and methodological variables were extracted from the included articles. In least-adjusted analyses, both the somatic/affective [hazard ratio (HR) 1.30, 95% confidence interval (CI) 1.19-1.41, p < 0.001] and cognitive/affective (HR 1.07, 95% CI 1.00-1.15, p = 0.05) dimensions of depressive symptoms were associated with cardiovascular prognosis. In fully adjusted analyses, somatic/affective symptoms were significantly associated with adverse prognosis (HR 1.19, 95% CI 1.10-1.29, p < 0.001) but cognitive/affective symptoms were not (HR 1.04, 95% CI 0.97-1.12, p = 0.25). An increase of one standard deviation (±1 s.d.) in the scores of the somatic/affective dimension was associated with a 32% increased risk of adverse outcomes (HR 1.32, 95% CI 1.17-1.48, p < 0.001). Somatic/affective depressive symptoms were more strongly and consistently associated with mortality and cardiovascular events in patients with heart disease compared with cognitive/affective symptoms. Future research should focus on the mechanisms by which somatic/affective depressive symptoms may affect cardiovascular prognosis.
    Psychological Medicine 01/2014; 44(13):1-15. DOI:10.1017/S0033291714000063 · 5.43 Impact Factor
  • Source
    • "Plenty of research has shown that besides physical suffering, patients commonly experience severe stressors and other psychological difficulties. These involve feelings of vulnerability [11, 18– 21], fear of death, posttraumatic stress disorder [22] [23] [24] [25] [26], loss of control [22] [23] [24] [25] [26], anxiety [2, 3, 6, 20, 23, 27–30], and depression [31] [32] [33] [34] [35] [36]. Particularly the importance of identifying incapacitating depression and anxiety has been emphasized in research [27–34, 37–41]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Patients recovering from a myocardial infarction (MI) are faced with a number of serious challenges. Aim. To create a substantive theory on myocardial infarction patients' coping as a continuum. Methods. Grounded theory method was used. Data were collected by using individual interviews. The informants were 28 MI patients. Results. The core category "coping experiences-a pathway towards different coping orientations" includes 2 main categories: "positive and negative coping experiences" (4 months after MI) and "different coping orientations" (12 months after MI). Conclusion. Coping with a myocardial infarction is a long-term dynamic process of dealing with varied emotions and adjustment needs. Coping is threatened, if the patient denies the seriousness of the situation, suffers from depression and emotional exhaustion, or if there are serious problems in the interaction with family members. This study stresses the importance of recognizing the patient's depressive state of mind and the psychological aspects which affect family dynamics. A more family-centered approach involving a posthospital counseling intervention is recommended. Relevance to Clinical Practice. The results of this study can be used in nursing care practice when organizing support interventions for myocardial infarction patients.
    12/2012; 2012:674783. DOI:10.1155/2012/674783
  • Source
    • "Lower medical adherence which is associated with poorer understanding of treatment recommendations, which in turn heightens anxiety about treatment adverse effects in depressed cancer patients (Ell et al., 2005). Depression also increases risk for morbidity and mortality in several chronic diseases, including AIDS (Ickovics et al., 2001) and cardiovascular disease (Barefoot et al., 2000). In addition, some evidence suggests that depressed cancer patients have increased morbidity and, possibly, mortality (Gallo et al., 2007; Spiegel and Giese-Davis, 2003), although findings among cancer survivors are less consistent (Goodwin et al., 2004; Steel et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over two-thirds of the 11.4 million cancer survivors in the United States can expect long-term survival, with many others living with cancer as a chronic disease controlled by ongoing therapy. However, behavioral co-morbidities often arise during treatment and persist long-term to complicate survival and reduce quality of life. In this review, the inter-relationships between cancer, depression, and sleep disturbance are described, with a focus on the role of sleep disturbance as a risk factor for depression. Increasing evidence also links alterations in inflammatory biology dynamics to these long-term effects of cancer diagnosis and treatment, and the hypothesis that sleep disturbance drives inflammation, which together contribute to depression, is discussed. Better understanding of the associations between inflammation and behavioral co-morbidities has the potential to refine prediction of risk and development of strategies for the prevention and treatment of sleep disturbance and depression in cancer survivors.
    Brain Behavior and Immunity 05/2012; 30. DOI:10.1016/j.bbi.2012.05.002 · 6.13 Impact Factor
Show more